MDxHealth Reports Half Year 2022 Results

NEWS RELEASE – REGULATED INFORMATION 25 AUGUST 2022, 4:00PM EDT, 22:00 CET MDxHealth Reports Half Year 2022 Results IRVINE, CA, and HERSTAL, BELGIUM – August 25, 2022 – MDxHealth SA (NASDAQ/Euronext: MDXH) (“mdxhealth” or the “Company“), a commercial-stage precision diagnostics company, today announced its financial results for the half year ended June 30, 2022. Michael […]

Mdxhealth’s New Share Capital Amount and New Number of Shares

NEWS RELEASE – REGULATED INFORMATION August 19, 2022, 4:00 PM EDT / 22:00 CET Mdxhealth‘s New Share Capital Amount and New Number of Shares IRVINE, CA, and HERSTAL, BELGIUM – August 19, 2022 – MDxHealth SA (NASDAQ/Euronext: MDXH) (“mdxhealth” or the “Company“), a commercial-stage precision diagnostics company, today a announces, in accordance with Article 15 […]

Mdxhealth Acquires Oncotype DX® GPS Prostate Cancer Business from Exact Sciences and Reports Preliminary Half Year 2022 Results

NEWS RELEASE – INSIDE AND REGULATED INFORMATION August 2, 2022, 4:00PM EDT / 22:00 CET Mdxhealth Acquires Oncotype DX® GPS Prostate Cancer Business from Exact Sciences and Reports Preliminary Half Year 2022 Results Solidifies leadership in the precision diagnostics urology market Provides the most comprehensive menu of advanced molecular tests for urology in prostate cancer Enhances scale […]

MDxHealth Reports Q1-2022 Results

   NEWS RELEASE – REGULATED INFORMATION27 APRIL 2022, 4:00PM EDT / 22:00 CET          MDxHealth Reports Q1-2022 Results